Nasdaq bcrx

This website uses cookies so that we can provide you with the best user experience possible.

BioCryst Pharmaceuticals, Inc. About the company. It is also developing BCX, an oral factor D inhibitor for complement-mediated diseases. Earnings are forecast to grow Trading at good value compared to peers and industry.

Nasdaq bcrx

See all ideas. See all brokers. EN Get started. Market closed Market closed. No trades. BCRX chart. Today 0. Key stats. Market capitalization. Dividend yield indicated.

Total assets.

Key events shows relevant news articles on days with large price movements. Ardelyx Inc. ARDX 2. Amarin Corporation plc. AMRN 1. TG Therapeutics Inc common stock. TGTX 1.

Key events shows relevant news articles on days with large price movements. Ardelyx Inc. ARDX 5. Amarin Corporation plc. AMRN 2. TG Therapeutics Inc common stock.

Nasdaq bcrx

See all ideas. See all brokers. EN Get started. Market closed Market closed. No trades. BCRX chart.

First national bank mitchell sd

Provides Earnings Guidance for the Year Nov Yes, you can track BioCryst Pharmaceuticals, Inc. Companies News. Listed exchange for this security. New minor risk - Shareholder dilution Nov A near test what is ba. Create a customised news feed, and subscribe to our regional newsletters. Earnings before interest, taxes, depreciation, and amortization, is a measure of a company's overall financial performance and is used as an alternative to net income in some circumstances. Negative shareholders equity. High number of new directors Nov Please consult your broker or financial representative to verify pricing before executing any trades. Cash and short-term investments.

.

Pharvaris NV. Register or. Strictly Necessary and Functional. You can contact us here. Spectral AI technology to revolutionise triage and treatment 07 Mar. Allow cookies Change settings. Effective tax rate. IOVA 0. News Browse. Amarin Corporation plc. Return on assets. The company was founded by William M. Cash from investing. Last Reported Earnings Dec 31, Earnings before interest, taxes, depreciation, and amortization, is a measure of a company's overall financial performance and is used as an alternative to net income in some circumstances.